Download PDF
1 / Pages

Other users also viewed these articles

cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis B Patricia Gita Naully; Marselina Irasonia Tan; Agustiningsih Agustiningsih; Caecilia Sukowati; Ernawati Arifin Giri-Rachman;
10.1016/j.aohep.2024.101533
A novel nomogram for predicting HBeAg seroclearance in HBeAg-positive chronic hepatitis B patients treated with nucleos(t)ide analogues Yan Gu; Yao Zhang; Zhiyi Zhang; Jian Wang; Qing Zhang; Shaoqiu Zhang; Yilin Liu; Jiacheng Liu; Juan Xia; Xiaomin Yan; Jie Li; Xingxiang Liu; Rui Huang; Chao Wu;
Ann Hepatol. 2024;29:
NAFLD is associated with less severe liver fibrosis in chronic hepatitis B: A multi-center, retrospective study Renling Yao; Sufang Lu; Ruifei Xue; Jian Wang; Yuanwang Qiu; Yuxin Chen; Jiacheng Liu; Li Zhu; Jie Zhan; Suling Jiang; Shengxia Yin; Xin Tong; Weimao Ding; Jie Li; Chuanwu Zhu; Rui Huang; Chao Wu;
Ann Hepatol. 2024;29: